Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | ATM | Q13315 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23790776 | 1.00 | L3MBTL1 (0.42) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL23790741 | 0.99 | L3MBTL1 (0.41) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL23790671 | 0.96 | L3MBTL1 (0.39) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL23790651 | 0.96 | L3MBTL1 (0.41) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL23790785 | 0.92 | KMT2A (0.41) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20385282 | 0.91 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL20385225 | 0.91 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL18126018 | 0.90 | L3MBTL1 (0.47) | L3MBTL1ATMKDM4EPTGER4KMT2A | |
| SCHEMBL20385320 | 0.90 | L3MBTL1 (0.46) | L3MBTL1ATMKDM4EKMT2AIL1R1 | |
| SCHEMBL20385284 | 0.90 | L3MBTL1 (0.44) | L3MBTL1ATMKDM4EKMT2AIL1R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-20210280798-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11818953-B2 | Heterocyclic compound, organic light-emitting device including heterocyclic compound, and electronic apparatus including organic light-emitting device | CYP2E1, CRY1, CYP1A1 | L3MBTL1 1215/4885ATM 3731/4885KDM4E 2979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.